| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Medicine | 1175 | 126 | 221 | 20 |
The concepts of Internal medicine, Oncology, Cancer, Surgery and Gastroenterology are tackled in Japanese Journal of Clinical Oncology. Chemotherapy regimen, Chemotherapy, Survival rate, Carcinoma and Breast cancer are all aspects of Internal medicine discussed in the journal. Japanese Journal of Clinical Oncology addresses concerns in Chemotherapy regimen which are intertwined with other disciplines, such as Regimen and Combination chemotherapy.
In the journal, researchers investigate the Carcinoma study as part of research in the field of Pathology. The studies on Pathology discussed can also contribute to research in the domains of Lung and Adenocarcinoma. The studies in Oncology featured incorporate elements of Stage (cooking), Colorectal cancer and Metastasis.
Most of the Cancer studies addressed also intersect with Incidence (epidemiology). Japanese Journal of Clinical Oncology tackles issues in Surgery, particularly in the topics of Radiation therapy and Retrospective cohort study. Issues in Gastroenterology were discussed, taking into consideration concepts from other disciplines like Neutropenia and Phases of clinical research.
The main points discussed in the most cited publications deal with Internal medicine, Oncology, Cancer, Surgery and Survival rate. The most cited articles feature Internal medicine research that overlaps with concepts in Gastroenterology. The published papers tackle studies in Metastasis and the interrelated subject of Radiology to gain insights into Oncology.
The scientific interests tackled in Japanese Journal of Clinical Oncology are Internal medicine, Oncology, Cancer, Radiology and Lung cancer. The journal focuses on Internal medicine but sometimes tackles the closely related topic of Gastroenterology which is concerned with Phases of clinical research. While work presented in the journal provided substantial information on Oncology, it also covered topics in Clinical trial, Regimen, Combination therapy, Nivolumab and Radiation therapy.
It explores issues in Nivolumab which can be linked to other research areas like Ipilimumab and Renal cell carcinoma. Japanese Journal of Clinical Oncology addresses concerns in Cancer which are intertwined with other disciplines, such as Stage (cooking), Multivariate analysis, Univariate analysis and Family medicine. The research on Hazard ratio featured in Japanese Journal of Clinical Oncology combines topics in other fields like Proportional hazards model, Retrospective cohort study and Urology.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Japanese Journal of Clinical Oncology (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Japanese Journal of Clinical Oncology (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 20.36% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 33.63% were posted by at least one author from the top 10 institutions publishing in the journal. Another 21.97% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 17.04% of all publications and 27.35% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
If this article has inspired you to consider a career in the multiple sub-fields that fall under oncology, be it Internal medicine, Oncology, Cancer, Surgery, or Gastroenterology, then it is crucial to obtain the necessary education and certification. To begin this journey, a good starting point can be becoming a registered nurse and then specializing in oncology. The path of becoming an oncology nurse differs from region to region. If you are situated in Indiana and are considering this path, this article provides detailed information on how to become a registered nurse in Indiana online.
Once you become a registered nurse, you can further advance your knowledge and professional experience in oncology through specialized training and education. Oncology specialties include but are not limited to radiation, pediatric, surgical, and gynecologic oncology. Continuing to read research papers published by seasoned professionals in the field and keeping up with new trends and studies can help shape your expertise and practice.
Being part of the oncology field means having the potential to contribute valuable research and insights to Japanese Journal of Clinical Oncology, or other reputable oncology journals. Expanding your knowledge and keeping up to date with the latest findings will not only broaden your perspective but could also provide opportunities to publish your own research findings, thus contributing to a collective body of knowledge in the field of oncology.
Yasuo Ohashi;Masataka Ikeda;Hideo Kunitoh;Mitsuru Sasako
(2020)Akihito Kawazoe;Kohei Shitara;Narikazu Boku;Takaki Yoshikawa
(2021)Fuyuhiko Motoi;Michiaki Unno
(2020)Yoshihiko Tomita;Yoshihiko Tomita;Tsunenori Kondo;Go Kimura;Takamitsu Inoue
(2020)Satoshi Nara;Minoru Esaki;Daisuke Ban;Takeshi Takamoto
(2020)Jiyun Lee;Bo Mi Ku;Joon Ho Shim;Joon Ho Shim;Yoon La Choi
(2020)Tatsuya Ioka;Junji Furuse;Akira Fukutomi;Junki Mizusawa
(2021)For those interested in exploring healthcare careers related to medicine, online degree programs offer flexible options to advance professionally. Aspiring nurses can consider accelerated paths such as rn to bsn online programs, which allow registered nurses to earn their Bachelor of Science in Nursing in as little as six months. These programs support career growth and improved patient care capabilities.
For individuals aiming to become nurse practitioners, understanding how many years to become a nurse practitioner is crucial. There are accelerated bridge programs designed to efficiently transition candidates from associate degrees to advanced practice roles.
Specifically, asn to np programs provide pathways for those holding an Associate of Science in Nursing to pursue a Master of Science in Nursing, specializing as nurse practitioners. These programs help meet the demand for advanced practitioners in diverse healthcare settings.
Salary expectations and job prospects vary widely depending on location and specialization. For example, a psychiatric nurse practitioner salary by state can differ significantly, reflecting regional healthcare needs and cost of living. Understanding these factors can guide career decisions in medicine and nursing fields.
